Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.240 Biomarker BEFREE Subsequently, GSK‑J4, a histone demethylase inhibitor, was employed to deplete P16INK4A in these cancer cell lines and an ex vivo culture system of a patient‑derived xenograft (PDX) endometrial tumor sample. 30896884

2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.240 GeneticVariation LHGDN P16 alterations increase the metastatic potential of endometrial carcinoma. 18790522

2008
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.240 Biomarker RGD Rearrangement and allelic imbalance on chromosome 5 leads to homozygous deletions in the CDKN2A/2B tumor suppressor gene region in rat endometrial cancer. 18558284

2008
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.240 AlteredExpression LHGDN Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia. 18199985

2007
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
CUI: C0014170
Disease: Endometrial Neoplasms
Endometrial Neoplasms 		0.240 GeneticVariation LHGDN P16(INK4a) overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas. 17498885

2007